Parathyroidectomy and the Risk of Major Cerebrovascular and Cardiovascular Events in the Elderly.

Autor: Grant RRC; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD., Moroz BE; Computing and Software Solutions for Science, LLC, Bethany Beach, DE., Nilubol C; Division of Nephrology and Hypertension, Department of Medicine, Medstar Georgetown University Medical Center, Washington, DC., Cahoon EK; Division of Cancer Epidemiology and Genetics, Biostatistics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Pfeiffer RM; Division of Cancer Epidemiology and Genetics, Biostatistics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Nilubol N; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Publikováno v: Annals of surgery [Ann Surg] 2023 Dec 01; Vol. 278 (6), pp. 1032-1037. Date of Electronic Publication: 2023 Jul 17.

Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.

Autor: Laha D; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Grant RRC; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Mishra P; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Boufraqech M; Department of Molecular Biosciences, College of Natural Sciences, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, USA., Shen M; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Zhang YQ; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Hall MD; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Quezado M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., De Melo MS; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Del Rivero J; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Zeiger M; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Nilubol N; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. naris.nilubol@nih.gov.

Publikováno v: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2022 Sep 23; Vol. 41 (1), pp. 282. Date of Electronic Publication: 2022 Sep 23.

Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis.

Autor: Green BL; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Grant RRC; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Richie CT; Genetic Engineering and Viral Vector Core, Intramural Research Program, Biomedical Research Center, National Institute on Drug Abuse, Baltimore, Maryland, USA., Chatterjee B; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Sampaio De Melo M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Barr FG; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Pacak K; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA., Agarwal SK; Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland, USA., Nilubol N; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Publikováno v: European journal of endocrinology [Eur J Endocrinol] 2022 Jul 01; Vol. 187 (1), pp. 185-196.

Elevated postoperative carcinoembryonic antigen guides adjuvant chemotherapy for stage II colon cancer: a multicentre cohort retrospective study.

Autor: Pu, Hongjiang¹ (AUTHOR), Yang, Wei¹ (AUTHOR), Liu, Mengmei² (AUTHOR), Pang, Xiaolin³ (AUTHOR), Chen, Yaxue⁴ (AUTHOR), Xiong, Qiuxia^5,6,7 (AUTHOR) xiongqiuxia1@kmmu.edu.cn

Publikováno v: Scientific Reports. 3/22/2024, Vol. 14 Issue 1, p1-13. 13p.

Decision Regret in Patients with Appendiceal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Autor: Graves A; Sunrise Hospital and Medical Center, Las Vegas, NV, USA., Sadjadi J; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA., Kosich M; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA., Ward E; Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT, USA., Sood D; Oregon Health and Science University, Portland, OR, USA., Fahy B; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA., Pankratz S; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA., Mishra SI; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA., Greenbaum A; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA. AGreenbaum@salud.unm.edu.; Department of Surgery, University of New Mexico Health Sciences Center, Albuquerque, NM, USA. AGreenbaum@salud.unm.edu.

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2024 Nov; Vol. 31 (12), pp. 7978-7986. Date of Electronic Publication: 2024 Aug 27.